Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bausch Health Companies Inc (BHC)

Bausch Health Companies Inc (BHC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,398,138
  • Shares Outstanding, K 370,083
  • Annual Sales, $ 9,625 M
  • Annual Income, $ -46,000 K
  • EBIT $ 2,628 M
  • EBITDA $ 4,032 M
  • 60-Month Beta 0.41
  • Price/Sales 0.25
  • Price/Cash Flow 0.83
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 67.00% ( +1.44%)
  • Historical Volatility 45.11%
  • IV Percentile 54%
  • IV Rank 19.92%
  • IV High 177.43% on 07/24/24
  • IV Low 39.53% on 03/19/25
  • Put/Call Vol Ratio 0.27
  • Today's Volume 374
  • Volume Avg (30-Day) 1,473
  • Put/Call OI Ratio 2.15
  • Today's Open Interest 141,768
  • Open Int (30-Day) 141,457

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate 0.97
  • Number of Estimates 4
  • High Estimate 1.10
  • Low Estimate 0.82
  • Prior Year 0.89
  • Growth Rate Est. (year over year) +8.99%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.93 +8.69%
on 06/23/25
7.24 -10.99%
on 07/02/25
+0.26 (+4.21%)
since 06/18/25
3-Month
4.41 +46.03%
on 05/23/25
7.24 -10.99%
on 07/02/25
+1.34 (+26.27%)
since 04/17/25
52-Week
3.96 +62.63%
on 07/24/24
9.85 -34.62%
on 11/04/24
-0.94 (-12.74%)
since 07/18/24

Most Recent Stories

More News
New Strong Sell Stocks for May 13th

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:AlTi Global, Inc. ALTI is a financial company which provides merchant banking, corporate advisory, brokerage and placement agency...

AMRK : 21.98 (-2.14%)
BHC : 6.45 (-0.46%)
ALTI : 4.44 (-1.77%)
Bausch Health Q1 Earnings and Revenues Miss Estimates, Stock Down

Shares of Bausch Health Companies Inc. BHC declined 3.81% after the company reported lower-than-expected first-quarter 2025 results.Adjusted earnings per share of 59 cents missed the Zacks Consensus Estimate...

BEAM : 20.79 (+1.66%)
FOLD : 6.02 (-4.29%)
ADMA : 16.69 (-5.12%)
BHC : 6.45 (-0.46%)
Bausch Health Announces First Quarter 2025 Results

First Quarter Consolidated Revenues of $2.26 billion, up 5% on a Reported basis and 6% on an Organic (non-GAAP) 1 basis over the prior year period

BHC.TO : 8.83 (-0.90%)
BHC : 6.45 (-0.46%)
Bausch Health Announces Health Canada Clearance of Solta Medical's Thermage(R) FLX System

A Long-Awaited Advancement in Non-Invasive Radiofrequency Skin Tightening Is Now Approved for the Canadian Market

BHC.TO : 8.83 (-0.90%)
BHC : 6.45 (-0.46%)
Bausch Health Announces Launch of Solta Medical's Fraxel FTX(TM)

The next generation of skin resurfacing technology will debut at the ASLMS 2025 Conference

BHC.TO : 8.83 (-0.90%)
BHC : 6.45 (-0.46%)
Bausch Health Announces Filing of Supplement to Proxy Statement

Supplement In Response to Company Learning that Carl Icahn and Affiliates Have Cash-Settled Equity Swaps for Approximately 90 Million of Its Common Shares

BHC.TO : 8.83 (-0.90%)
BHC : 6.45 (-0.46%)
U.S. District Court Grants Summary Judgment in Favor of FDA, Salix, and Teva, and Against Norwich

LAVAL, QC / ACCESS Newswire / April 17, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch Health"), and its gastroenterology business Salix Pharmaceuticals, Inc., today...

BHC.TO : 8.83 (-0.90%)
BHC : 6.45 (-0.46%)
Bausch Health Announces Adoption of Shareholder Rights Plan

LAVAL, QC / ACCESS Newswire / April 14, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch Health") announces today that its board of directors (the "Board") has approved...

BHC.TO : 8.83 (-0.90%)
BHC : 6.45 (-0.46%)
Bausch Health Announces Ortho Dermatologics 2025 ASPIRE HIGHER Scholarship Program

Bausch Health is offering scholarships to six students impacted by dermatologic conditions, with application submissions open through June 11, 2025

BHC.TO : 8.83 (-0.90%)
BHC : 6.45 (-0.46%)
Bausch Health, Canada Inc. and the pan-Canadian Pharmaceutical Alliance Sign Letter of Intent for Public Drug Plan Coverage of (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris

LAVAL, QC / ACCESS Newswire / April 9, 2025 / Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced that it has signed a letter of intent with the pan-Canadian...

BHC.TO : 8.83 (-0.90%)
BHC : 6.45 (-0.46%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic...

See More

Key Turning Points

3rd Resistance Point 6.69
2nd Resistance Point 6.61
1st Resistance Point 6.54
Last Price 6.45
1st Support Level 6.40
2nd Support Level 6.32
3rd Support Level 6.25

See More

52-Week High 9.85
Fibonacci 61.8% 7.60
Fibonacci 50% 6.91
Last Price 6.45
Fibonacci 38.2% 6.21
52-Week Low 3.96

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar